1. To examine possible regulatory roles of liver and kidney in cobalamin metabolism, specific activities of the two cobalamin-dependent enzymes, uptake in vivo of cyano [57Co]cobalamin ([57Co]CNCbl) and the binding of [57Co]Cbl to intracellular proteins were measured in normal, cobalamin-loaded and cobalamin-deficient rats. Cobalamin deficiency and cobalamin loading produced greater changes in cobalamin concentration in the kidney than in the liver.
1. To examine possible regulatory roles of liver and kidney in cobalamin metabolism, specific activities of the two cobalamin-dependent enzymes, uptake in vivo of cyano [57Co]cobalamin ([57Co]CNCbl) and the binding of [57Co]Cbl to intracellular proteins were measured in normal, cobalamin-loaded and cobalamin-deficient rats. Cobalamin deficiency and cobalamin loading produced greater changes in cobalamin concentration in the kidney than in the liver.
2. Although cobalamin deficiency resulted in a decrease in total methylmalonyl-coenzyme A mutase (methylmalonyl-CoA mutase) in both organs, cobalamin loading had no effect. Neither deficiency nor loading altered total methyltransferase activity. The holoenzyme activities of both enzymes correlated with changes in tissue cobalamin levels.
3. Uptake of [57Co]Cbl indicated that the kidney, in contrast to the liver, increased its uptake during loading and reduced it during deficiency, suggesting a possible regulatory role for this organ.
4. In the normal rat, 24 h after injection of was present in the free form. During deficiency free renal [57Co]Cbl was reduced to 0.6% of the administered [57Co]Cbl whereas in cobalaminloaded rats it was increased to more than 27%.
5. It is concluded that alterations in tissue cobalamin levels resulting from differences in cobalamin supply are due to changes in the large pool of free cobalamin present in the kidney and not to changes in the intracellular binding.
Introduction
In mammals the bulk of the cobalamin (vitamin BIZ) is present in the liver and kidney and as a result, these tissues may constitute important sites for any homoeostatic mechanism which may regulate cobalamin metabolism. Liver has been regarded as having a central role in cobalamin homoeostasis with the hepatic cobalamin representing a relatively large stable store available to the rest of the body [ 1-31.
A number of findings have challenged this concept; studies on patients with pernicious anaemia have shown that bone marrow becomes megalo-blastic and depletion of hepatic cobalamin has not occurred [4] . Studies on the regulation of cobalamin homoeostasis in the rat showed that the isolated perfused liver released cobalamin at a rate indicative of a rapid flux between liver and plasma [5] . However, during cobalamin deficiency the fractional rate of hepatic cobalamin release actually decreased and conservation of hepatic cobalamin was observed [6] .
Changes in hepatic and renal cobalamin levels in response to alterations in cobalamin supply may be due to differences in the binding of cobalamin in these tissues. In the rat cobalamin binds t o the transport protein transcobalamin I1 (TC 11) and to the two intracellular cobalamin-dependent enzymes, methylmalonyl-CoA mutase (methylmalonyl-coenzyme A mutase; EC 5.4.99.1) and methyltransferase (5 -methyltetrahydropteroyl-Lglutamate : L-homocysteine S methykransferdse; EC 2.1 . I .13), which are present in relatively high concentrations in the liver and kidney. In the present study the uptake of cobalamin by liver and kidney, the activity of the intracellular enzymes and their binding to cobalamin have been examined in rats subjected to varying cobalamin supply. Male Sprague-Dawley rats (250-350 g) were used. Normal rats were fed pellets supplied by Feed Supplies. Brisbane. containing 75 nmol of cobalamin/kg. Cobalamin-deficient rats were obtained either 6 weeks after total gastrectomy [7] or by dietary deprivation of cobalamin t o weanling rats; these rats were carefully maintained in individual stainless steel cages and supplied daily with il fresh cobalamin-free diet (composition of the diet is given in Clinical Science Table 84/1 deposited with the Librarian, Royal Society of Medicine. 1 Wimpole Street, London WIM 8AE, from whom copies are available on request) for 3 months. Rats subjected to an overload of cyanocobalamin were given daily intraperitoneal injections of 1Opg of cyanocobalamin for 14 days before they were killed. Rats subjected to trace labelling were injected intravenously with 2 pCi (9.1 ng) of [57Co]CNCbl, at 4, 24 or 9 0 h before they were killed.
Methods
Animals were killed by stunning and cervical dislocation and the liver and kidneys removed and weighed. Samples (100-300 mg) were stored at -20°C before cobalamin assay. Tissue cobalamin levels were measured with an isotopic dilution method [8] and protein estimated by a modified Lowry assay [9] .
Homogenates were prepared by homogenizing tissues (2 g) in a hand-held homogenizer in 1 : 6 (w/v) ice-cold Tris-HC1 (3.4 mmol/l), pH 8.4, containing GSH (2 mmol/l). Methylmalonyl-CoA mutase activity was measured in the supernatant after centrifugation at 1 4 0 0 g for 2 min at 4°C.
Methyltransferase activity was measured in the supernatant after centrifugation at 37 000 g for 9 0 min at 4°C.
Methylmalonyl [14] . Total enzyme and holoenzyme activities were measured in the presence and absence of methylcobalamin (50 fmol). Uptake of [57Co]CNCbl into the liver and kidney in vivo was determined by measuring radioactivity in the tissue homogenates. Homogenates were sonicated (four times for 15 s) before centrifugation at 3 7 000 g for 9 0 min at 4°C and the supernatants (5-10 ml) were applied to a 2.6 cm x 90 cm Sephacryl S-200 (Pharmacia) column. Gel filtration was carried out as previously described [12, 151 .
Results
Gastrectomy resulted in a decrease in body weight (255 g compared with 377 g; P<O.OOl), liver weight (9.3 g compared with 12.3 g; P<O.OOS) and kidney weight (1 3.5 g compared with 2.24 g;
The results of cobalamin measurements on liver and kidney tissues subjected to different cobala-P < 0.0 I). min supply are shown in Table 1 . In normal rats the cobalamin concentration in the kidney was 12 times that in the liver. There was no significant change in the concentration of hepatic cobalamin as a result of cobalamin loading, but the concentration of cobalamin present in the kidney increased fivefold, to 60 times that present in the liver.
Cobalamin deficiency was more marked and more consistent in those animals which had bee5 gastrectomized compared with dietary deficient rats. There was a large decrease in both hepatic and renal cobalamin, with a higher percentage reduction in kidney (92.1%) than in liver (82.4%).
To determine whether the activities of the cobalamin-dependent enzymes were affected by changes in the cobalamin concentration, methylmalonyl-CoA mutase and methyltransferase activities were measured in liver and kidney tissues. The results are shown in Figs. 1 and 2 .
The results show that for the mutase enzyme, although the holoenzyme activity was always higher (P < 0.005) in the kidney, the total enzyme activity was always greater (P<O.Ol) in the liver. In the tissues from cobalamin-loaded animals, although there was an increase (P<O.OOl) in the holoenzyme levels there was no increase in the total enzyme activities. The addition of adenosylcobalamin t o the assay still resulted in a twofold stimulation of mutase activity in the cobalaminloaded kidney in spite of the high concentration of cobalamin present in the tissue.
In the gastrectomized rats there was a reduction (P<O.OOl) in both the holo-and total enzyme activities in both tissues compared with normal rats; a similar trend was also evident in the cobalamin-free dieted rats but there was a greater variation in the assays which may have been due to the differences in the cobalamin concentrations of these tissues (Table 1) .
Results for the methyltransferase assays are shown in Fig. 2 . Not only the holoenzyme activity but also the total enzyme activity was higher (P<O.OOl) in the kidney than in the liver. There was a significant increase ( P < O . O l ) in holoenzyme activity but not in total enzyme activity in the liver from cobalamin-deficient rats. Otherwise the activities were not significantly altered. The incorporation of a trace dose of [57Co]-CNCbl by liver and kidney was followed in normal, cobalamin-loaded and gastrectomized rats. In addition the binding of [57Co]CNCbl to the different proteins was examined by gel chroniatography.
[57Co]CNCbl was injected intravenously and the distribution of radioactivity was measured after different time intervals. Results for the uptake of [57Co]CNCbl by liver and kidney are shown in Fig. 3 . The incorporation of radioactivity into each tissue as a percentage of the administered [57Co]CNCbl is shown and the ratios of radioactivity present in kidney compared with liver after different time intervals are also given.
In all rats the uptake of radioactivity was greater by kidney than liver. In normal and loaded rats, after 4 h there was 5 times the amount of [57Co]Cbl present in kidney compared with liver. In these rats the ratio of radioactivity in kidney compared with liver increased with time owing to the increasing incorporation of [57Co]Cbl by kidney and the relatively constant amount of radioactivity present in liver. In the cobalaminloaded rats the radioactivity taken up by the kidney was twice that in the normal rats.
In the cobalamin-deficient rats the proportion of the administered [57Co]Cbl present in the liver was almost twice that found in normal rats. Moreover the incorporation of ['%o)Cbl by kidney was only marginally greater than liver and the amount of radioactivity present in kidney did not increase with time. Consequently the ratio of renal to hepatic cobalamin remained relatively constant and was much lower than in normal rats.
Supernatants from liver and kidney homogenates obtained from normal, cobalamin-loaded and gastrectomized rats, which had been injected with
[57Co]CNCbl, were chromatographed on Sephacryl S-200. Gel filtration on Sephacryl S-200 of the 37 000 g supernatants prepared from either liver or kidney homogenates yielded four peaks containing "Co radioactivity. The first peak eluted in the void volume and contained material excluded from the column matrix. The radioactivity in this peak may have been free or bound [57Co]Cbl entrapped in membrane fragments which failed to sediment. The second peak eluted with an apparent molecular weight (Mr) of 158 000 which has been shown to contain the cobalamin-dependent enzymes methylmalonyl-CoA mutase and methyltransferase [ 12, 151. The third peak consisted of TC I1 (M, 37 000), and finally the fourth peak eluted as free cobalamin. Recovery of the radioactivity applied to the column was over 85%. The percentage of administered 57C0 radioactivity present in the four peaks is shown in Fig. 4 .
A comparison of the distribution of radioactivity between liver and kidney supernatants in normal rats showed very different patterns. At [57Co]Cbl was accompanied by a corresponding
The binding of [57Co]CNCbl in liver and kidney decrease in TC 11-bound [57Co]Cbl. In kidney, from cobalamin-loaded rats was examined at 4 h however, there was no change in the distribution and 24 h after administration of [57Co]CNCbl. In of radioactivity between 4 h and 96h; in all liver the changes in TCIII-bound and enzymekidney supernatants prepared ,from normal rats bound [57Co]Cbl were very similar to normal rats approximately 80% of the 57C0 was present as free with the percentage of radioactivity bound to the cobalamin. enzyme increasing from 12% at 4 h to 58% at 24 h, and a corresponding decrease in the TC IIbound fraction from 63% to 28%. As in normal rats, about 80% of the radioactivity present in kidney at both 4 h and 24 h occurred as free cobalamin. At 24 h more than a quarter of the dose administered to the loaded rat was present as free cobalamin. The binding of [s7Co]Cbl in gastrectomized rats was examined; in liver a similar transfer of TC IIbound [57Co]Cbl to enzyme-bound [57Co]Cbl occurred between 4 h and 96 h as was found in both normal and cobalamin-loaded rats. The percentage of radioactivity bound to TC I1 was slightly greater than in normal rats and the [s7Co]-Cbl present as free cobalamin was reduced. However, the most marked difference in [57Co]Cbl binding was found in the cobalamin-deficient kidney. In the deficient kidney [57Co]Cbl was not present in large amounts as free cobalamin. The distribution of radioactivity corresponded more to that of liver; a comparison of binding at 96 h with that at 4 h showed an increase in enzyme-bound [s7Co]Cbl from 26% to 72% and a decrease in TC 11-bound [57Co]Cbl from 57% to 24%.
Discussion
In an attempt t o define the different hepatic and renal cobalamin levels in response to alterations in cobalamin supply, changes in the intracellular enzymes and their binding to cobalamin have been examined. No previous studies have been carried out to determine the specific activities of both methylmalonyl-CoA mutase and methyltransferase in both liver and kidney in response to changes in cobalamin supply. Activities of either methylmalonyl-CoA mutase or methyltransferase in liver from cobalamin-deficient rats have been determined [16-211; however, in most of these only holoenzyme activity was measured. More recent data [22] have indicated that holoenzyme activity may reflect in part the dissociation of cobalamin from the enzyme due to the assay conditions and therefore both total and holoenzyme activity should be measured. Beck [23] has suggested that elevated methylmalonyl-CoA mutase levels may compensate in part for cobalamin deficiency and increased apoenzyme levels have been reported in cobalamin-deficient rat liver [17] and human leucocytes [24] . In the present study no increase in mutase apoenzyme was observed during cobalamin deficiency; instead there was a highly significant decrease in both holoenzyme and total enzyme activities in both liver and kidney. The reduction in holoenzyme activity as a percentage of total activity can probably be explained simply by the reduction in cobalamin resulting from deficiency, whereas the reduction in total enzyme may be due to either reduced synthesis, or instability of the apoenzyme [22] . No increase in total mutase activity was observed in the cobalamin-loaded rats. In the kidney from the cobalamin-loaded animals the holoenzyme activity was found to be approximately 50% of the total activity, which was consistent with the percentage saturation observed in cobalamin-supplemented human fibroblasts [22] .
Previous studies on the response of methyltransferase to cobalamin deficiency have shown a reduction in hepatic enzyme activity in rats [21] , fruit bats [25] and chickens [26] . In contrast, the present studies did not show a decrease in either holoenzyme or total enzyme activity, but instead an increase in hepatic holoenzyme activity. This increase in holoenzyme activity in the liver may be due to the increased proportion of methylcobalamin present in rat liver in response to cobalamin deficiency [6, 271. Measurements of the cobalamin present in rat liver and kidney have given a wide range o f values between different studies . A higher concentration of cobalamin is present in the kidney and can vary from 8 [28] to 30 [30] times the level present in the liver. The diet on which the rats are fed appears to determine renal cobalamin stores. Rats used in earlier studies in this laboratory (J. A. Owens, unpublished work) had a cobalamin concentration of 844 ng of cobalamin/g of kidney, half the value found in normal rats in these experiments (Table 1 ). This increase in renal cobalamin coincided with a change in the diet given to the rats; it is probable that differences in diet may account for the wide range of concentrations previously reported. Rats have generally been rendered cobalamin deficient by maintaining them on a cobalamin-free diet, but this can result in variable deficiency. Gastrectomy in the present studies resulted in more consistent and greater deficiency. Rats which had been injected with 140 pg of CNCbl showed a marked increase in renal cobalamin but no increase in hepatic cobalamin (Table 1) . These results confirm previous reports for cobalamin-supplemented rats [31, 191 . It would appear that changes in cobalamin supply are reflected by changes in the cobalamin concentration of the kidney.
The intravenous injection of a trace dose of [s7Co]CNCbl enables the transport of cobalamin into liver and kidney to be followed. Although equilibration is not attained for over 30 days [32] quantitative and qualitative differences between the tissues in both the uptake and the binding of [57Co]Cbl were evident at 4 h. These differences were related to the cobalamin status of the tissues. The higher incorporation of radioactive cobalamin into kidney than into liver (Fig.  3) confirms previous results [33 -35] . Our results are also consistent with previous studies showing increased renal uptake in cobalamin-loaded rats [36] and decreased renal uptake together with increased hepatic uptake in cobalamin-deficient animals [37] .
Cobalamin in rat plasma is bound to TC I1 and the pinocytotic uptake of TC 11-bound [57Co]Cbl and its subsequent release by different hepatic subcellular fractions have been followed [38] . Newmark The presence of a large pool of free cobalamin in the kidney indicates a unique role for this organ as the storage site for cobalamin in the rat. Our studies suggest that this unbound cobalamin is available to the rest of the body when needed. With the onset of cobalamin deficiency this store of free cobalamin is depleted rather than the enzyme-bound cobalamin present in the liver and kidney.
